NYLIM
USNA icon

New York Life Investment Management’s Usana Health Sciences USNA Stock Holding History

New York Life Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,532
Closed -$297K – 1529
2023
Q4 		$297K Sell
5,532
-128
-2% -$6.47K ﹤0.01% 1220
2023
Q3 		$332K Sell
5,660
-892
-14% -$55.8K ﹤0.01% 1056
2023
Q2 		$413K Sell
6,552
-1,010
-13% -$64.3K ﹤0.01% 942
2023
Q1 		$476K Buy
+7,562
New +$451K 0.01% 997

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

New York Life Investment Management's USNA Position: Q1 2024 in Review

New York Life Investment Management sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 5,532 shares — an estimated $297K sold.

New York Life Investment Management first reported a position in USNA in Q1 2023 and held it in 4 quarters. The position peaked at $476K in Q1 2023. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.

  • New York Life Investment Management reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 5,532 Usana Health Sciences shares in Q1 2024, an estimated $297K.
  • New York Life Investment Management first reported a position in Usana Health Sciences in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Usana Health Sciences position peaked at $476K in Q1 2023.
  • 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.